Página Inicial CNEA Laboratorio TANDAR Página Inicial TANDAR Historia del acelerador TANDAR Web interno Web mail
Inicio » Actividades I+D > Publicaciones 2015 > Reprint of Application of BNCT to the tr...
acta de conferencia
"Reprint of Application of BNCT to the treatment of HER2+ breast cancer recurrences: Research and developments in Argentina"
M.A. Gadan, S.J. González, M. Batalla, M.S. Olivera, L. Policastro and M.L. Sztejnberg
Proc. of the "16th International Congress on Neutron Capture Therapy" (ICNCT-16), Helsinki, Finland, June 14-19, 2014. Ed. Hanna Koivunoro, Stuart Green, Iiro Auterinen and Martti Kulvik
Appl. Radiat. Isot. 106 (2015) 260-264
Abstract
In the frame of the Argentine BNCT Project a new research line has been started to study the application of BNCT to the treatment of locoregional recurrences of HER2+ breast cancer subtype. Based on former studies, the strategy considers the use of immunoliposomes as boron carriers nanovehicles to target HER2 overexpressing cells. The essential concerns of the current stage of this proposal are the development of carriers that can improve the efficiency of delivery of boron compounds and the dosimetric assessment of treatment feasibility. For this purpose, an specific pool of clinical cases that can benefit from this application was determined. In this work, we present the proposal and the advances related to the different stages of current research.
SUBGERENCIA TECNOLOGIA Y APLICACIONES DE ACELERADORES
Contacto
Av. Gral Paz y Constituyentes, San Martín, Pcia. de Buenos Aires, Argentina
Tel: (54-11) 6772-7007 - Fax: (54-11) 6772-7121